Clinical Outcome in Patients With Spinal Dural Arteriovenous Fistulas (COPSDAVF)
COPSDAVF
1 other identifier
observational
300
1 country
1
Brief Summary
Spinal dural arteriovenous fistulas (SDAVFs) are the most common vascular disorder of the spine and account for approximately 70% of spinal vascular malformation.They are a rare pathology with an excepted incidence of only 5-10 new cases per million inhabitants per year. Most fistulas are found in the thoracolumbar region and \> 80% of all SDAVFs are located between T6 and L2, whereas the cranio-cervical, cervical and sacral fistulas are more rare. SDAVFs have an overwhelmingly male predominance (80%), with an age presentation in the fifth or sixth dacede. It is presumed that SDAVFs are acquired diseases. A typical SDAVF is located inside the dural mater close to nerve root. It is fed by a radiculomeningeal artery and enters a radicular vein that merges in the perimedullary plexus. The presence of a shunt leads to a reversal of blood flow to the spinal cord venous system, which then induces venous hypertensive myelopathy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
June 14, 2017
CompletedFirst Posted
Study publicly available on registry
June 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedApril 22, 2021
April 1, 2021
10.1 years
June 14, 2017
April 21, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of the spinal cord function
Modified Aminoff \& Logue's Scale for evaluating the spinal cord function
1 day before operation and 3 months, 6 months, 12 months postoperation
Secondary Outcomes (1)
Modified Denis Pain and Numbness Scale (mDPNS)
1 day before operation and 3 months, 6 months, 12 months postoperation
Eligibility Criteria
all patients with spinal dural arteriovenous fistulas admitted to department of neurosurgery in Xuanwu Hospital and department of neurosurgery in Beijing Haidian Hospital.
You may qualify if:
- patient diagnosed with spinal dural arteriovenous fiatulas
- the fiatula locate between C2 and L5
- patient not received surgical or interventional treatment before
- patient with normal cardiac, renal and hepatic function
- patient capable of understanding the content of the patient information / Informed Consent Form
- patient willing and able to participate in the registry
You may not qualify if:
- patient received surgical treatment or interventional treatment before
- patient is pregnant patient allergic to iodine
- patient unable to complete follow-up
- patient with cerebral lesions patient with other spinal lesions
- patient with cardiac, renal or hepatic dysfunction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hongqi Zhang, MDlead
- Beijing Haidian Hospitalcollaborator
Study Sites (1)
Neurosurgery Department of Xuanwu hospital, Capital Medical University
Beijing, Beijing Municipality, 100053, China
Related Publications (6)
Cenzato M, Versari P, Righi C, Simionato F, Casali C, Giovanelli M. Spinal dural arteriovenous fistulae: analysis of outcome in relation to pretreatment indicators. Neurosurgery. 2004 Oct;55(4):815-22; discussion 822-3. doi: 10.1227/01.neu.0000137630.50959.a7.
PMID: 15458589RESULTSteinmetz MP, Chow MM, Krishnaney AA, Andrews-Hinders D, Benzel EC, Masaryk TJ, Mayberg MR, Rasmussen PA. Outcome after the treatment of spinal dural arteriovenous fistulae: a contemporary single-institution series and meta-analysis. Neurosurgery. 2004 Jul;55(1):77-87; discussion 87-8. doi: 10.1227/01.neu.0000126878.95006.0f.
PMID: 15214976RESULTFugate JE, Lanzino G, Rabinstein AA. Clinical presentation and prognostic factors of spinal dural arteriovenous fistulas: an overview. Neurosurg Focus. 2012 May;32(5):E17. doi: 10.3171/2012.1.FOCUS11376.
PMID: 22537126RESULTSherif C, Gruber A, Bavinzski G, Standhardt H, Widhalm G, Gibson D, Richling B, Knosp E. Long-term outcome of a multidisciplinary concept of spinal dural arteriovenous fistulae treatment. Neuroradiology. 2008 Jan;50(1):67-74. doi: 10.1007/s00234-007-0303-4. Epub 2007 Nov 20.
PMID: 18026943RESULTSaladino A, Atkinson JL, Rabinstein AA, Piepgras DG, Marsh WR, Krauss WE, Kaufmann TJ, Lanzino G. Surgical treatment of spinal dural arteriovenous fistulae: a consecutive series of 154 patients. Neurosurgery. 2010 Nov;67(5):1350-7; discussion 1357-8. doi: 10.1227/NEU.0b013e3181ef2821.
PMID: 20871454RESULTKrings T, Geibprasert S. Spinal dural arteriovenous fistulas. AJNR Am J Neuroradiol. 2009 Apr;30(4):639-48. doi: 10.3174/ajnr.A1485. Epub 2009 Feb 12.
PMID: 19213818RESULT
Study Officials
- STUDY DIRECTOR
Zhang Hongqi, MD.PHD.
Xuanwu Hospital, Beijing
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
June 14, 2017
First Posted
June 20, 2017
Study Start
March 1, 2013
Primary Completion
March 31, 2023
Study Completion
March 31, 2025
Last Updated
April 22, 2021
Record last verified: 2021-04